Real-World Health Care Services Utilization Associated With the Management of Patients With Relapsed and Refractory Multiple Myeloma in Spain: The CharisMMa Study

[Background]: Most patients with multiple myeloma (MM) relapse or become refractory, resulting in high health care costs. However, real-world data regarding the utilization of health care services among the relapsed/refractory MM (RRMM) population are scarce.

Detalles Bibliográficos
Autores: Ocio, Enrique M., Montes, Carmen, Bustamante, Gabriela, Garzón, Sebastián, González, Esther, Pérez-Persona, Ernesto, González-Calle, Verónica, Sirvent, Maialen, Arguiñano, José M., González, Yolanda, Ríos, Rafael, Miguel Llorente, Dunia de, Grande, Marta, Fernández-Nistal, Alonso, Naves, Andrea, Rosiñol, Laura
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2023
País:España
Institución:Consejo Superior de Investigaciones Científicas (CSIC)
Repositorio:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/352567
Acceso en línea:http://hdl.handle.net/10261/352567
Access Level:acceso abierto
Palabra clave:Burden
Cost of illness
Multiple myeloma
Therapy
Monoclonal gammopathy
Descripción
Sumario:[Background]: Most patients with multiple myeloma (MM) relapse or become refractory, resulting in high health care costs. However, real-world data regarding the utilization of health care services among the relapsed/refractory MM (RRMM) population are scarce.

Similares en LA Referencia